Biologic Induction Agents
Biologic Induction Agents is a class of therapeutic biologics, primarily monoclonal antibodies or fusion proteins, that selectively target immune cell components or signaling pathways to achieve rapid and potent immunosuppression during the induction phase of transplant rejection prophylaxis.
55
Publications
2.8K
Citations
334
Authors
137
Institutions
Publications per year
2017–2026
11
Parents
55
Gaetano Ciancio, George W. Burke, Jeffrey J. Gaynor et al. · Transplantation · 2005 · 218 citations
Pharmacy, Immunology, Nephrology +17
1–5 of 55
334
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 334
137
University of Michigan
Ann Arbor, United States
4 h-index
11 publications
492 citations

Western University
London, Canada
3 h-index
5 publications
157 citations
University of Miami
Coral Gables, United States
3 h-index
14 publications
795 citations
Northwestern University
Evanston, United States
3 h-index
4 publications
493 citations
The Catholic University of Korea Seoul St. Mary's Hospital
Seoul, South Korea
2 h-index
23 publications
407 citations

Washington University in St. Louis
St Louis, United States
2 h-index
4 publications
193 citations
Terasaki Foundation
Los Angeles, United States
2 h-index
3 publications
343 citations

Cedars-Sinai Medical Center
Los Angeles, United States
2 h-index
2 publications
355 citations
1–8 of 137
9 publications · 905 citations
9
h-index
3 publications · 97 citations
3
h-index
Repository · 3 publications · 55 citations
3
h-index
3 publications · 55 citations
3
h-index
NDT · 3 publications · 80 citations
3
h-index
1–5